Therapeutic Advances in Neurological Disorders
Scope & Guideline
Empowering progress in neurological science and practice.
Introduction
Aims and Scopes
- Neurological Disorders Research:
The journal emphasizes research related to a wide range of neurological disorders, including multiple sclerosis, Parkinson's disease, epilepsy, and neuromuscular disorders. It aims to provide insights into the pathophysiology, diagnosis, and treatment of these conditions. - Clinical Trials and Efficacy Studies:
A significant focus is on clinical trials evaluating the efficacy and safety of therapeutic interventions. The journal publishes systematic reviews and meta-analyses that synthesize evidence from clinical studies to guide treatment decisions. - Innovative Therapeutic Approaches:
The journal explores novel therapeutic strategies, including pharmacological treatments, immunotherapies, and emerging technologies such as gene therapy and neurostimulation techniques. - Multidisciplinary Collaboration:
There is a strong emphasis on collaboration among various specialties within neurology, combining insights from clinical practice, basic research, and patient-centered care to advance treatment paradigms. - Patient-Centric Research:
The journal prioritizes studies that consider patient perspectives, treatment adherence, and quality of life, reflecting a commitment to improving patient outcomes in neurological disorders.
Trending and Emerging
- Precision Medicine in Neurology:
An increasing number of studies focus on precision medicine approaches, tailoring treatments based on individual patient characteristics such as genetic profiles and biomarkers. This trend is indicative of a broader movement towards personalized healthcare. - Neuroinflammation and Immune Modulation:
Research on neuroinflammation and its role in various neurological disorders is gaining prominence, with a focus on immune modulation therapies. This reflects a growing understanding of the immune system's impact on neurological health. - Digital Health and Telemedicine:
The integration of digital health technologies and telemedicine in managing neurological disorders is trending, particularly following the COVID-19 pandemic. Studies exploring the effectiveness of remote monitoring and treatment are becoming more common. - Real-World Evidence and Patient Registries:
There is a significant increase in the use of real-world evidence and patient registries to inform treatment patterns and outcomes. This trend emphasizes the importance of understanding how therapies perform in everyday clinical settings. - Machine Learning and Artificial Intelligence:
The application of machine learning and AI in predicting outcomes and personalizing treatment plans for neurological disorders is emerging as a significant area of research, reflecting the intersection of technology and medicine.
Declining or Waning
- Traditional Pharmacotherapy:
There has been a noticeable decline in publications focusing solely on traditional pharmacotherapy for neurological disorders, possibly due to the increasing interest in novel therapies and personalized medicine. - Basic Science Studies:
Research articles centered exclusively on basic science without direct clinical implications have decreased, as the journal shifts toward more translational research that bridges laboratory findings with clinical applications. - Single-Center Studies:
The prevalence of single-center observational studies has waned, likely due to a preference for multi-center collaborations that enhance the generalizability of findings and provide a broader patient perspective. - Historical Perspectives:
There is less emphasis on historical reviews of treatments and practices in neurology, as the focus has moved towards current innovations and future directions in therapeutic approaches. - Focus on Rare Disorders:
The journal appears to have reduced its emphasis on rare neurological disorders, potentially due to the limited available research and funding compared to more prevalent conditions.
Similar Journals
Neurology Research International
Shaping the Future of Clinical NeurologyNeurology Research International, published by HINDAWI LTD, is an esteemed open access journal that has been serving the neurology community since 2010. With its ISSN 2090-1852 and E-ISSN 2090-1860, this journal aims to foster knowledge dissemination and facilitate dialogue surrounding key issues in neurology and clinical neuroscience, making it a vital resource for researchers, clinicians, and students alike. It operates from the United States, with its administrative hub located in London, England. As of 2023, the journal has been positioned in the Q3 category for both neurology and clinical neurology, reflecting its commitment to advancing research within these critical fields. With a current Scopus rank of #216/400 in clinical neurology and a #113/192 in neuroscience, and a converged publication timeline from 2010 to 2024, Neurology Research International is dedicated to promoting high-quality research that addresses contemporary challenges and innovations in neurological science. By offering open access since its inception, it ensures that cutting-edge research is freely available, aligning with the global push towards accessible scientific communication.
Expert Review of Neurotherapeutics
Advancing the Frontiers of NeurotherapeuticsExpert Review of Neurotherapeutics is an esteemed journal published by Taylor & Francis Ltd, focusing on the rapidly evolving field of neurotherapeutics. With an ISSN of 1473-7175 and an E-ISSN of 1744-8360, this publication aims to bridge the gap between clinical and preclinical research, providing a platform for innovative therapeutic strategies in neurology and neuroscience. The journal boasts impressive impact factor rankings, categorized as Q2 in both clinical neurology and miscellaneous neuroscience, and Q1 in medical pharmacology for 2023. Its reputable placement in Scopus rankings, including Rank #82/400 in clinical neurology, underscores its significance within the medical research community. Spanning from 2001 to 2024, the journal publishes critical reviews and original research articles aimed at enhancing understanding and treatment in neurological disorders. Although it currently does not offer open access, articles published in the journal are crucial for researchers, healthcare professionals, and students seeking to stay at the forefront of advancements in neurotherapeutics. With its strong emphasis on rigorous peer-reviewed content, Expert Review of Neurotherapeutics continues to be a vital resource for those dedicated to improving patient outcomes in the realm of neurology.
RESTORATIVE NEUROLOGY AND NEUROSCIENCE
Nurturing Knowledge: Bridging Research and Clinical Practice in NeuroscienceRESTORATIVE NEUROLOGY AND NEUROSCIENCE, published by IOS PRESS, is a premier journal dedicated to advancing the fields of neurology and neuroscience. Since its inception in 1989, this journal has played a crucial role in disseminating cutting-edge research findings and innovative therapeutic approaches that aim to restore neurological function and improve patient outcomes. With a focus on developmental neuroscience and clinical neurology, the journal holds a 2023 Scopus ranking of #129 out of 400 in clinical neurology, and #15 out of 37 in developmental neuroscience, reflecting its significant influence in these domains. Although it operates on a non-open access model, RESTORATIVE NEUROLOGY AND NEUROSCIENCE offers valuable insights for researchers, healthcare professionals, and students seeking to deepen their understanding of neural restoration mechanisms and therapeutic strategies. Located in Amsterdam, Netherlands, the journal continues to foster scholarly dialogue and innovation, contributing to the global advancement of neuroscience and neurology.
LYMPHOLOGY
Elevating the discourse in lymphatic studies.LYMPHOLOGY is a distinguished journal dedicated to the study of lymphatic biology, hematology, and immunology, published by the esteemed LYMPHOLOGY organization since its inception in 1968. As a key resource within the scientific community, it holds a notable place in the academic landscape with a 2023 Scopus ranking of #47 in Hematology and #120 in Immunology and Allergy, reflecting its commitment to advancing knowledge through empirical research and critical reviews. Although it is not an Open Access journal, its relevance is underlined by a Q3 category in both hematology and immunology, providing a platform for groundbreaking research that addresses key challenges in these fields. Researchers and professionals will find invaluable insights and innovative methodologies within its pages, reinforcing its role as a vital contributor to advancing scientific understanding and clinical practice in lymphology and related disciplines.
Clinical Parkinsonism & Related Disorders
Advancing knowledge on Parkinsonism and beyond.Clinical Parkinsonism & Related Disorders is a prominent open-access journal published by Elsevier, focused on advancing the understanding and treatment of Parkinson's disease and related neurological conditions. Since its inception in 2019, this journal has aimed to provide a platform for high-quality research, review articles, and clinical studies dedicated to elucidating the complexities of Parkinsonism and its comorbidities. With an E-ISSN of 2590-1125, it has swiftly established its role in the field of clinical neurology, currently ranked in the Q3 quartile for clinical neurology and Q4 for cellular and molecular neuroscience. While its Scopus rankings reflect a competitive landscape, occupying the 241st position in clinical neurology and the 83rd in neuroscience, the journal remains committed to fostering scholarly dialogue and supporting innovative research. Researchers, clinicians, and students will find valuable insights within its pages, contributing to ongoing discourse and the pursuit of effective therapeutic strategies. Access to all articles has been made available since 2019, emphasizing the journal's mission to disseminate knowledge widely and enhance accessibility in the scientific community.
NEUROLOGIC CLINICS
Illuminating the complexities of the nervous system.NEUROLOGIC CLINICS, published by W B SAUNDERS CO-ELSEVIER INC, stands as a leading journal in the field of clinical neurology, boasting an impressive impact factor that reflects its significant contributions to neurological research and clinical practice. With an ISSN of 0733-8619 and E-ISSN of 1557-9875, this journal provides a critical platform for the dissemination of innovative research, case studies, and reviews focusing on various aspects of neurology, from diagnosis to treatment interventions. As part of its commitment to advancing the understanding of neurological disorders, NEUROLOGIC CLINICS is categorized in the Q2 quartile for Neurology (clinical) in 2023, indicating its robust standing within the academic community. It is recognized for its rigorous peer-review process and is indexed in Scopus, ranking #147 out of 400 in its field with a notable 63rd percentile. The journal, which dates back to 1983 and continues to publish vital findings up to 2024, is an invaluable resource for researchers, healthcare professionals, and students dedicated to enhancing their knowledge and clinical skills in neurology. Subscribe now to stay abreast of current advancements and expand your expertise in this dynamic field.
Physiotherapy
Leading the Way in Sports Therapy ResearchPhysiotherapy, published by Elsevier Science Ltd, stands as a prestigious journal in the field of Physical Therapy, Sports Therapy, and Rehabilitation. Since its inception in 1945, this journal has been committed to advancing the practice and science of physiotherapy through rigorous peer-reviewed research, making significant contributions to both clinical practice and academia. With an impressive Q1 ranking and a Scopus percentile of 88th, it is widely regarded as a leading source of evidence-based information for professionals and researchers alike. The journal operates without an Open Access option, which ensures that it maintains the quality and integrity of the research it publishes while providing exclusive access to valuable insights for its subscribers. By focusing on diverse topics within its scope, including therapeutic techniques, rehabilitation strategies, and sports medicine, Physiotherapy continues to shape the future of physiotherapy practice and education, making it an essential resource for anyone invested in this dynamic field.
Progress in Neurology and Psychiatry
Connecting researchers and clinicians for impactful insights.Progress in Neurology and Psychiatry is a pivotal journal published by John Wiley & Sons Ltd, dedicated to advancing the fields of neurology and psychiatry. With a robust history dating back to its establishment, this esteemed journal holds a consistent Q3 ranking in 2023 across several categories including Neurology, Clinical Neurology, Psychiatry, and Mental Health, signifying its significant contribution to the scientific community. This journal serves as a vital source of knowledge and insight, publishing original research, reviews, and case studies that explore the intricacies of neurological and psychiatric disorders. Although it does not offer open access, the journal remains accessible to a wide audience through institutional subscriptions. By fostering a platform for scholarly discourse, Progress in Neurology and Psychiatry aims to bridge the gap between research and practice, ultimately enhancing the quality of care for individuals with neurological and psychiatric conditions. Researchers, clinicians, and students are encouraged to engage with the journal's comprehensive content to stay informed of the latest developments and emerging trends in these critical fields of medicine.
Seminars in Pediatric Neurology
Exploring the forefront of pediatric neurological research.Seminars in Pediatric Neurology, published by W B SAUNDERS CO-ELSEVIER INC, is a prestigious journal dedicated to the evolving field of pediatric neurological disorders. Since its inception in 1994, this peer-reviewed journal has provided critical insights and cutting-edge research to support healthcare professionals in enhancing the quality of care for children with neurological conditions. With an impressive 2023 impact factor and a Q2 ranking in both the clinical neurology and pediatrics categories, it stands as a vital resource, fostering the dissemination of knowledge among researchers and clinicians alike. Featuring articles that explore a range of topics from clinical trials to innovative treatment modalities, this journal empowers practitioners with the latest findings in pediatric neurology. While primarily subscription-based, it plays a key role in bridging the gap between academia and clinical practice, making it an indispensable tool for anyone involved in the care and treatment of pediatric neurological patients.
NEUROPEDIATRICS
Innovating treatment strategies for young minds.NEUROPEDIATRICS is a prominent academic journal published by GEORG THIEME VERLAG KG, dedicated to advancing the understanding and treatment of neurological disorders in children. Established in 1980, this journal has consistently provided a platform for innovative research and clinical practice in the fields of pediatrics and neurology, culminating in its recognition across various rankings; it holds a Q2 rating in Pediatrics, Perinatology and Child Health, and Q3 in both Medicine (miscellaneous) and Neurology (clinical) as of 2023. While NEUROPEDIATRICS is not an open access journal, it remains a crucial resource for researchers, clinicians, and students who seek cutting-edge insights and evidence-based practices in the management of pediatric neurological issues. As a result, NEUROPEDIATRICS plays an indispensable role in shaping future research directions and improving health outcomes in this vital field.